A.N.M. Wymenga

Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms

A.N.M. Wymenga, Barbro Eriksson, Pasi Salmela et al. · Journal of Clinical Oncology · 1999 · 223 citations

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

Marije E. Hamaker, Caroline Seynaeve, A.N.M. Wymenga et al. · The Breast · 2013 · 133 citations

Nursing, Geriatric Oncology, Oncology +11

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Bonne Biesma, A.N.M. Wymenga, Andrew Vincent et al. · Annals of Oncology · 2011 · 100 citations

Geriatric Oncology, Elderly Patients, Geriatrics +8

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study

Ciska Buijs, Constantijne H. Mom, Pax H.B. Willemse et al. · Breast Cancer Research and Treatment · 2008 · 89 citations · Full text

Breast Oncology, Breast Cancer Patients, Medicine +7

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Carolien H. Smorenburg, S.M. de Groot, A. Elise van Leeuwen‐Stok et al. · Annals of Oncology · 2014 · 60 citations · Full text

Breast Oncology, Oncology, Elderly Patients +8